Regentis Biomaterials Ltd.
RGNT
New York Stock Exchange Arca1.49
USD
+0.02
- -
Total Valuation
Regentis Biomaterials Ltd. carries a market capitalization of 10.47M, placing it among publicly traded companies globally.
| Market Cap | 10.47M |
| Enterprise Value | N/A |
Stock Price Statistics
Regentis Biomaterials Ltd.'s stock has declined approximately -80.13333% over the past 52 weeks. The 50-day moving average sits at 1.88, while the 200-day moving average is 3.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -80.13333% |
| 50-Day Moving Average | 1.88 |
| 200-Day Moving Average | 3.11 |
| Average Volume (20 Days) | N/A |